Bioequivalence
Bioequivalence studies play a critical role in bringing safe, effective, and affordable therapies to patients. CenExel partners with sponsors to conduct high-quality bioequivalence research that demonstrates therapeutic equivalence between generic and reference products while meeting regulatory requirements and timelines.
Studies Conducted
Acute & post-surgical pain focus
0
+
Trial Participants
Enrolled in acute pain studies
0
+
Active Sites
Specialized research locations
0
Overview
Comprehensive Bioequivalence Research Solutions
Our bioequivalence research programs support pharmaceutical and biotechnology sponsors throughout the development and approval process for generic and reformulated products.
With extensive experience in pharmacokinetic (PK), pharmacodynamic (PD), fasting, fed-state, and comparative bioavailability studies, our teams deliver accurate data collection, regulatory compliance, and efficient study execution.
From protocol development through final reporting, CenExel provides the scientific expertise and operational excellence needed to accelerate product development and regulatory submissions.
Conditions Covered
Bioequivalence Studies We Conduct
Our research sites support a broad range of bioequivalence and comparative pharmacology studies.
Oral Solid Dosage Forms
Modified Release Products
Immediate Release Formulations
Generic Drug Development
Comparative Bioavailability Studies
Fasting Studies
Fed-State Studies
Pharmacokinetic Studies
Pharmacodynamic Assessments
Drug-Drug Interaction Studies
Our Approach
Why Sponsors Choose CenExel for Bioequivalence
Our bioequivalence expertise extends beyond study execution—we provide strategic scientific guidance and operational efficiency throughout every phase of development.
01
Regulatory Expertise
Deep understanding of FDA and global bioequivalence requirements.
02
Specialized PK Capabilities
Extensive experience in pharmacokinetic sampling, analysis, and reporting.
03
Rapid Recruitment
Access to diverse healthy volunteer populations for timely enrollment.
04
High-Quality Data
Consistent study execution with robust quality assurance processes.
Phase Coverage
Supported Trial Phases
CenExel supports a wide range of bioequivalence and comparative bioavailability studies, including pilot studies, pivotal registration studies, food-effect assessments, and specialized pharmacokinetic evaluations.
Active across all phases
Phase I
Phase II
Phase III
Phase IV
Bioequivalence Task Force
CenExel's Bioequivalence Task Force brings together experienced clinical pharmacologists, principal investigators, and operational specialists to support complex bioequivalence programs.
Active Sites
15 Sites
CenExel Gaithersburg
CenExel Garden Grove
CenExel Atlanta
CenExel Marlton
CenExel Hollywood
Related Therapeutic Areas
Also in Pain & Inflammation
